In addition, CLK1 inhibitor TG-003 and inhibitors of SRPKs and CLKs, called Cpd-1, Cpd-2 and Cpd-3, are shown to suppress the proliferation of breast cancer cells [121,122]. Here, CLK1 is linked to breast cancer.